XML 17 R55.htm IDEA: XBRL DOCUMENT v3.20.1
Business Combination - Narrative (Details)
$ / shares in Units, shares in Millions, $ in Millions
1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended
Dec. 30, 2019
USD ($)
Nov. 21, 2019
USD ($)
shares
Oct. 01, 2019
USD ($)
Aug. 01, 2019
USD ($)
Oct. 01, 2018
USD ($)
Jul. 31, 2018
Dec. 11, 2017
Nov. 30, 2019
USD ($)
Sep. 30, 2019
$ / shares
Sep. 28, 2019
USD ($)
Mar. 28, 2020
USD ($)
Mar. 30, 2019
USD ($)
Nov. 20, 2019
Business Acquisition [Line Items]                          
Consideration transferred   $ 69.3                      
Ownership percentage   78.00%                      
Goodwill                   $ 2,563.7 $ 2,592.0    
Equity interest in acquiree, remeasurement gain   $ 3.2                      
Consideration related to equity method investment   17.9                      
Consideration related to newly acquired shares               $ 12.6          
Consideration, portion related to loan repayment   30.2                      
Business Combination, Consideration related to fair value of noncontrolling interest   8.6                      
Discount rate percentage                       0.120  
Intangible assets, net                   1,459.8 $ 1,328.8    
Emsor                          
Business Acquisition [Line Items]                          
Period of cumulative revenue to trigger payment of contingent consideration liability             2 years            
Faxitron | Developed technology                          
Business Acquisition [Line Items]                          
Weighted average period           9 years              
Faxitron | Customer relationships                          
Business Acquisition [Line Items]                          
Weighted average period           9 years              
Faxitron | Trade names                          
Business Acquisition [Line Items]                          
Weighted average period           8 years 3 months 18 days              
Focal Therapeutics                          
Business Acquisition [Line Items]                          
Consideration transferred     $ 12.5   $ 120.1                
Purchase price withheld         $ 14.0             $ 1.5  
Period for payment of contingent consideration liabilities         1 year                
Goodwill         $ 31.1                
Focal Therapeutics | Developed technology                          
Business Acquisition [Line Items]                          
Identifiable intangible assets         $ 83.1                
Weighted average period         11 years                
Focal Therapeutics | In-process research and development                          
Business Acquisition [Line Items]                          
Identifiable intangible assets         $ 11.4                
Focal Therapeutics | In-process research and development | Minimum | Discount Rate                          
Business Acquisition [Line Items]                          
Intangible assets, fair value (percentage)         15.50%                
Focal Therapeutics | In-process research and development | Maximum | Discount Rate                          
Business Acquisition [Line Items]                          
Intangible assets, fair value (percentage)         16.50%                
Focal Therapeutics | Trade names                          
Business Acquisition [Line Items]                          
Identifiable intangible assets         $ 2.7                
Weighted average period         13 years                
SuperSonic Imagine                          
Business Acquisition [Line Items]                          
Consideration transferred   12.6   $ 18.2                  
Equity interest in acquiree, Percentage       46.00%             81.00%    
Goodwill   22.4                      
Other assets   $ 6.5                      
Percentage of outstanding shares acquired       46.00%                 50.00%
Cash tender offer price (per share) | $ / shares                 $ 1.50        
Shares acquired | shares   7.6                      
Customer relationships   $ 4.0                      
Alpha Imaging [Member]                          
Business Acquisition [Line Items]                          
Consideration transferred $ 18.0                        
Holdback                       1.0  
Purchase price withheld                     $ 0.9    
Customer relationships                       $ 18.1  
Health Beacons [Member]                          
Business Acquisition [Line Items]                          
Consideration transferred                     19.3    
Holdback                     2.3    
Goodwill                     5.7    
Intangible assets, net                     10.7    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities                     $ 2.9    
Other Income                          
Business Acquisition [Line Items]                          
Income (loss) from equity method investments                   $ 3.3